BE829830A - Composition pour traiter la schizophrenie - Google Patents

Composition pour traiter la schizophrenie

Info

Publication number: BE829830A
Authority: BE; Belgium
Prior art keywords: composition; treat schizophrenia; schizophrenia; treat
Prior art date: 1974-06-03

Application number

BE156998A

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1974-06-03

Filing date

1975-06-03

Publication date

1975-10-01

1975-06-03 Application filed filed Critical

1975-10-01 Publication of BE829830A publication Critical patent/BE829830A/fr

Links

201000000980 schizophrenia Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

BE156998A 1974-06-03 1975-06-03 Composition pour traiter la schizophrenie BE829830A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US05/475,856 US3947579A (en)	1974-06-03	1974-06-03	Method and composition for potentiating neuroleptic drugs

Publications (1)

Publication Number	Publication Date
BE829830A true BE829830A (fr)	1975-10-01

Family

ID=23889440

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE156998A BE829830A (fr)	1974-06-03	1975-06-03	Composition pour traiter la schizophrenie

Country Status (12)

Country	Link
US (1)	US3947579A (fr)
AU (1)	AU499034B2 (fr)
BE (1)	BE829830A (fr)
CA (1)	CA1048932A (fr)
DE (1)	DE2523998A1 (fr)
FR (1)	FR2272646B1 (fr)
GB (2)	GB1514311A (fr)
IE (1)	IE41374B1 (fr)
IL (1)	IL47324A (fr)
NL (1)	NL7506404A (fr)
PH (1)	PH13894A (fr)
ZA (1)	ZA753316B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2453643A2 (fr) *	1977-06-24	1980-11-07	Synthelabo	Compositions pharmaceutiques actives sur le systeme nerveux central
US4160835A (en) *	1976-11-19	1979-07-10	Merck & Co., Inc.	Antihypertensive compositions containing an arylsubstituted alanine and a phenyl hydrazinopropionic acid
NL7706429A (nl) *	1977-06-10	1978-12-12	Univ Erasmus	Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking.
US4148896A (en) *	1978-02-22	1979-04-10	E. I. Du Pont De Nemours And Company	Antidepressant combination
US4346085A (en) *	1980-02-29	1982-08-24	Massachusetts Institute Of Technology	Process and composition for treating disorders by administering amphetamine and choline
NL8006135A (nl) *	1980-11-10	1982-06-01	Univ Erasmus	Geneesmiddel met angst en angstequivalenten opheffende werking en werkwijze voor de bereiding van een dergelijk geneesmiddel.
US4636494A (en) *	1981-01-30	1987-01-13	Massachusetts Institute Of Technology	Process and composition for treating disorders by administering amphetamine and choline
DK373383A (da)	1982-08-20	1984-02-21	Midit	Fremgangsmaade til fremstilling af omega-aminosyrederivater
US5296277A (en) *	1992-06-26	1994-03-22	Minnesota Mining And Manufacturing Company	Positionable and repositionable adhesive articles
US5637617A (en) *	1994-04-01	1997-06-10	The Regents Of The University Of California	Methods for use of GABAa receptor GABAergic compounds
US20050192220A1 (en) *	2001-02-05	2005-09-01	Gevys Pharmaceuticas Ltd.	Composition and method for potentiating drugs
US6833377B2 (en)	2001-02-05	2004-12-21	Gevys Pharmaceuticals Ltd.	Composition and method for potentiating drugs
US7544681B2 (en)	2001-09-27	2009-06-09	Ramot At Tel Aviv University Ltd.	Conjugated psychotropic drugs and uses thereof
ES2379544T3 (es)	2001-09-27	2012-04-27	Ramot At Tel Aviv University Ltd.	Conjugado de perfenazina y GABA y usos del mismo
EP2272537A3 (fr) *	2005-06-07	2014-10-22	Ramot at Tel-Aviv University Ltd.	Sels de conjuguées de médicaments psychotropiques et procédés pour leur synthèse
CA2610838A1 (fr) *	2005-06-07	2006-12-14	Ramot At Tel Aviv University Ltd.	Nouveaux sels de medicaments psychotropes conjugues et leurs procedes de preparation
WO2008010223A2 (fr)	2006-07-17	2008-01-24	Ramot At Tel Aviv University Ltd.	Conjugués de gaba anti-douleur
US8207369B2 (en)	2008-02-11	2012-06-26	Ramot At Tel-Aviv University Ltd.	Conjugates for treating neurodegenerative diseases and disorders
EP2291181B9 (fr)	2008-04-18	2013-09-11	University College Dublin National University Of Ireland, Dublin	Utilisation de la captodiamine pour le traitement des symptômes de la dépression
EP2509603A1 (fr)	2009-12-09	2012-10-17	Biolinerx Ltd.	Procédés d'amélioration des fonctions cognitives
WO2012038963A1 (fr)	2010-09-22	2012-03-29	Ramot At Tel-Aviv University Ltd.	Sel d'addition d'acide d'un conjugué nortriptyline-gaba et son procédé de préparation
WO2016176609A1 (fr)	2015-04-30	2016-11-03	Ovid Therapeutics Inc	Procédés de traitement du syndrome de prader-willi
US9351968B1 (en)	2015-09-09	2016-05-31	Ovid Therapeutics Inc	Methods of treating developmental disorders using pipradrol
WO2017205606A1 (fr)	2016-05-26	2017-11-30	Ovid Therapeutics Inc.	Procédés de traitement de syndromes du comportement à l'aide de pipradrol
US10071083B2 (en)	2017-02-03	2018-09-11	Ovid Therapeutics Inc	Use of gaboxadol in the treatment of tinnitus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH449645A (de) *	1963-07-09	1968-01-15	Ciba Geigy	Verfahren zur Herstellung neuer Aminosäuren
US3505451A (en) *	1967-08-14	1970-04-07	Geigy Chem Corp	Compositions and methods for alleviating schizophrenia employing one of haloperidol,trifluperidol or an acid addition salt thereof and one of desipramine,imipramine and an acid addition salt thereof

1974
- 1974-06-03 US US05/475,856 patent/US3947579A/en not_active Expired - Lifetime
1975
- 1975-04-30 FR FR7513709A patent/FR2272646B1/fr not_active Expired
- 1975-05-16 GB GB20777/75A patent/GB1514311A/en not_active Expired
- 1975-05-16 GB GB1591/78A patent/GB1514312A/en not_active Expired
- 1975-05-20 IL IL47324A patent/IL47324A/xx unknown
- 1975-05-22 AU AU81438/75A patent/AU499034B2/en not_active Expired
- 1975-05-22 ZA ZA00753316A patent/ZA753316B/xx unknown
- 1975-05-28 CA CA75227970A patent/CA1048932A/fr not_active Expired
- 1975-05-30 DE DE19752523998 patent/DE2523998A1/de not_active Ceased
- 1975-05-30 NL NL7506404A patent/NL7506404A/xx not_active Application Discontinuation
- 1975-06-03 BE BE156998A patent/BE829830A/fr not_active IP Right Cessation
- 1975-06-03 IE IE1237/75A patent/IE41374B1/xx unknown
- 1975-06-03 PH PH17222A patent/PH13894A/en unknown

Also Published As

Publication number	Publication date
IE41374B1 (en)	1979-12-19
FR2272646A1 (fr)	1975-12-26
DE2523998A1 (de)	1975-12-11
US3947579A (en)	1976-03-30
GB1514312A (en)	1978-06-14
FR2272646B1 (fr)	1978-11-10
NL7506404A (nl)	1975-12-05
PH13894A (en)	1980-10-27
IL47324A (en)	1979-03-12
AU8143875A (en)	1976-11-25
IE41374L (en)	1975-12-03
CA1048932A (fr)	1979-02-20
ZA753316B (en)	1976-04-28
GB1514311A (en)	1978-06-14
IL47324A0 (en)	1975-08-31
AU499034B2 (en)	1979-04-05

Legal Events

Date

Code

Title

Description

1985-12-31

RE

Patent lapsed

Owner name: NELSON RESEARCH & DEVELOPMENT CY

Effective date: 19850603

Publication	Publication Date	Title
BE829830A (fr)	1975-10-01	Composition pour traiter la schizophrenie
BE824782A (fr)	1975-07-24	Compositions pour le traitement de gingivite
IT1032583B (it)	1979-06-20	Composizione antitraspirante
SE411047B (sv)	1979-11-26	Bituminos komposition
IT1034453B (it)	1979-09-10	Composizione detergente
IT1031312B (it)	1979-04-30	Composizione detergenti
IT1030965B (it)	1979-04-10	Composizione pimentarie
SE7509920L (sv)	1976-03-08	Fenolhartskomposition
BE827213A (fr)	1975-09-26	Composition de polysocyanates
FR2278649A1 (fr)	1976-02-13	Composition hydraulique
FR2297904A1 (fr)	1976-08-13	Composition pour
SE7806517L (sv)	1978-06-02	Insekticid komposition
IT1026540B (it)	1978-10-20	Composizione refrattaria
BE828753A (fr)	1975-09-01	Composition detergente
DK315575A (da)	1976-01-13	Hydraulisk komposition
BE837701A (fr)	1976-07-19	Composition pour la prophylaxie dentaire
SE7508308L (sv)	1976-01-23	Peptidkomposition
BE828522A (fr)	1975-10-29	Composition pour empecher la formation de tartre alcalin
IT1031570B (it)	1979-05-10	Migliorata composizione antischiuma
RO83510A (fr)	1984-08-17	Composition herbicide-liquide
FR2280394A1 (fr)	1976-02-27	Nouvelle composition antiseptique
SE7512565L (sv)	1976-05-17	Formbar komposition
RO69336A (fr)	1983-02-01	Composition herbicide sinergetique
MX160632A (es)	1990-03-29	Composicion dentifrica mejorada
JPS5132415A (ja)	1976-03-19	Denhokokan